APA (7th ed.) Citation

Razazi, K., Berti, E., Cecchini, J., Carteaux, G., Habibi, A., Bartolucci, P., . . . Dessap, A. M. (2024). Decreased risk of underdosing with continuous infusion versus intermittent administration of cefotaxime in patients with sickle cell disease and acute chest syndrome. PLoS ONE, 19(4), 1. https://doi.org/10.1371/journal.pone.0302298

Chicago Style (17th ed.) Citation

Razazi, Keyvan, et al. "Decreased Risk of Underdosing with Continuous Infusion Versus Intermittent Administration of Cefotaxime in Patients with Sickle Cell Disease and Acute Chest Syndrome." PLoS ONE 19, no. 4 (2024): 1. https://doi.org/10.1371/journal.pone.0302298.

MLA (9th ed.) Citation

Razazi, Keyvan, et al. "Decreased Risk of Underdosing with Continuous Infusion Versus Intermittent Administration of Cefotaxime in Patients with Sickle Cell Disease and Acute Chest Syndrome." PLoS ONE, vol. 19, no. 4, 2024, p. 1, https://doi.org/10.1371/journal.pone.0302298.